Brazil, June 2, 2015. Illumina, Inc. (NASDAQ:ILMN) today announced it has named Pensabio, a life science, analytical instruments and diagnostics distributor, headquartered in Sao Paolo, Brazil, as its new distribution partner to deliver Illumina sequencing platforms, products and solutions in Brazil.
"Pensabio was selected to distribute Illumina products because of its strong presence and reputation as an excellent provider of instruments and services in Brazil," said Vice President and General Manager Mark Van Oene of Americas Commercial Operation at Illumina. "Through the synergy of this partnership we will transform our services and better meet the growing market demands for our Brazilian customers."
Pensabio is now taking orders from customers in Brazil. Customers will have full access to Illumina's best-in-class products and services, including the world's most comprehensive next-generation sequencing systems, assays, and core consumables.
Pensabio will leverage its extensive experience in logistical support, technical expertise in analytical instrumentation, and network to deliver a faster turnaround time, enhanced customer experience and user-friendly ordering process.
About Illumina, Inc.
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.
About Pensabio
Pensabio is a company belonging to the Group Pensalab which has more than 20 years in the Brazilian market with vast operation throughout the territory. Besides the Pensabio company, the Group Pensalab also comprises of the Pensalab company, the Metrohm/Pensalab company and the Pensacom company, totalizing more than 350 employees and four offices in Brazil and in the US. The Pensabio company will also have sales teams, support and services. Visit http://www.pensabio.com.br.
Forward-Looking Statements
This release may contain forward-looking statements that involve risks and uncertainties. Important factors that could cause actual results to differ materially from those in any forward-looking statements are detailed in our filings with the Securities and Exchange Commission, including our most recent filings on Forms 10-K and 10-Q, or in information disclosed in public conference calls, the date and time of which are released beforehand. We do not intend to update any forward-looking statements after the date of this release.
Investors:
Rebecca Chambers
858-255-5243
rchambers@illumina.com
Media:
Mina Nicoletti
858-882-6822
pr@illumina.com
Press Release
